Mira Pharmaceuticals, Inc.
CIK: 0001904286
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TELO
Telomir Pharmaceuticals, Inc.
10% Owner
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About MIRA PHARMACEUTICALS, INC.
MIRA PHARMACEUTICALS, INC. (SEC CIK 0001904286) files insider reports with the SEC as 10% Owner of Telomir Pharmaceuticals, Inc. (TELO).
Signal8 holds 1 ownership filing by MIRA PHARMACEUTICALS, INC., a Form 3, filed on Oct 3, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on MIRA PHARMACEUTICALS, INC.'s filings is in MIAMI, FL.
Other insiders filing for Telomir Pharmaceuticals, Inc. (TELO)
- Whalen Matthew Pratt, Director
- MacPherson Edward Clouston, Director
- Del Giudice Matthew Paul, Director
- Mushak Andriy, Chief Financial Officer
- Aminov Erez, CEO and Chairman
- Weichselbaum Alan, Chief Financial Officer